beconase allergy & hayfever beclometasone dipropionate 0.5mg/g (50 micrograms per actuation) aqueous nasal spray bottle
viatris pty ltd - beclometasone dipropionate, quantity: 500 microgram/g - spray, nasal - excipient ingredients: polysorbate 80; dispersible cellulose; hydrochloric acid; glucose; purified water; benzalkonium chloride; phenethyl alcohol - for the prophylaxis or treatment of allergic rhinitis for up to 6 months in adults and children 12 years and over.
fostair 100/6 beclometasone dipropionate 100 microgram and formoterol fumarate dihydrate 6 microgram pressurised inhalation solution
chiesi australia pty ltd - beclometasone dipropionate, quantity: 100 microgram; formoterol fumarate dihydrate, quantity: 6 microgram - inhalation, pressurised - excipient ingredients: norflurane; ethanol absolute; hydrochloric acid - asthma fostair is indicated in adults (18 years and older) in the treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids (ics) and 'as needed' inhaled rapid-acting beta2-agonist or - patients already adequately controlled on both ics and long-acting beta2-agonists (laba). (see section 4.2 dose and method of administration for treatment approaches). copd (fostair 100/6 only) symptomatic treatment of adults with severe copd (fev1 less than 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.
fostair 200/6 beclometasone dipropionate 200 microgram and formoterol fumarate dihydrate 6 microgram pressurised inhalation solution
chiesi australia pty ltd - beclometasone dipropionate, quantity: 200 microgram; formoterol fumarate dihydrate, quantity: 6 microgram - inhalation, pressurised - excipient ingredients: norflurane; ethanol absolute; hydrochloric acid - asthma fostair is indicated in adults (18 years and older) in the treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids (ics) and 'as needed' inhaled rapid-acting beta2-agonist or - patients already adequately controlled on both ics and long-acting beta2-agonists (laba). (see section 4.2 dose and method of administration for treatment approaches).
beconase aqueous
b & s healthcare - beclometasone dipropionate - nasal spray suspension - 50 microgram
beconase aqueous nasal spray
mcdowell pharmaceuticals - beclometasone dipropionate - nasal spray suspension - 50 microgram
beclometasone 50micrograms/dose nasal spray
a a h pharmaceuticals ltd - beclometasone dipropionate - spray - 50microgram/1dose
beclometasone 50micrograms/dose nasal spray
actavis uk ltd - beclometasone dipropionate - spray - 50microgram/1dose
beclometasone 50micrograms/dose nasal spray
viatris uk healthcare ltd - beclometasone dipropionate - spray - 50microgram/1dose
beclometasone 50micrograms/dose nasal spray
kent pharma (uk) ltd - beclometasone dipropionate - spray - 50microgram/1dose
beclometasone 50micrograms/dose nasal spray
alliance healthcare (distribution) ltd - beclometasone dipropionate - spray - 50microgram/1dose